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Microglia cells protect neurons by direct engulfment of invading
neutrophil granulocytes: a new mechanism of CNS immune
privilege
Abstract
Microglial cells maintain the immunological integrity of the healthy brain and can exert protection from
traumatic injury. During ischemic tissue damage such as stroke, peripheral immune cells acutely
infiltrate the brain and may exacerbate neurodegeneration. Whether and how microglia can protect from
this insult is unknown. Polymorphonuclear neutrophils (PMNs) are a prominent immunologic infiltrate
of ischemic lesions in vivo. Here, we show in organotypic brain slices that externally applied invading
PMNs massively enhance ischemic neurotoxicity. This, however, is counteracted by additional
application of microglia. Time-lapse imaging shows that microglia exert protection by rapid engulfment
of apoptotic, but, strikingly, also viable, motile PMNs in cell culture and within brain slices. PMN
engulfment is mediated by integrin- and lectin-based recognition. Interference with this process using
RGDS peptides and N-acetyl-glucosamine blocks engulfment of PMNs and completely abrogates the
neuroprotective function of microglia. Thus, engulfment of invading PMNs by microglia may represent
an entirely new mechanism of CNS immune privilege.
Neurobiology of Disease
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Microglial cells maintain the immunological integrity of the healthy brain and can exert protection from traumatic injury. During
ischemic tissue damage such as stroke, peripheral immune cells acutely infiltrate the brain and may exacerbate neurodegeneration.
Whether and how microglia can protect from this insult is unknown. Polymorphonuclear neutrophils (PMNs) are a prominent immu-
nologic infiltrate of ischemic lesions in vivo. Here, we show in organotypic brain slices that externally applied invading PMNsmassively
enhance ischemic neurotoxicity. This, however, is counteracted by additional application of microglia. Time-lapse imaging shows that
microglia exert protection by rapid engulfment of apoptotic, but, strikingly, also viable, motile PMNs in cell culture and within brain
slices. PMN engulfment is mediated by integrin- and lectin-based recognition. Interference with this process using RGDS peptides and
N-acteyl-glucosamineblocks engulfmentofPMNsandcompletely abrogates theneuroprotective functionofmicroglia. Thus, engulfment
of invading PMNs by microglia may represent an entirely newmechanism of CNS immune privilege.
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Introduction
Abundant evidence exists that an inflammatory response is
mounted within the CNS after cerebral ischemia. Postischemic
inflammation comprises the infiltration of polymorphonuclear
granulocytes andmonocytes/macrophages into the injured brain
parenchyma, activation of microglia, and expression of proin-
flammatory cytokines, adhesionmolecules, and other inflamma-
tory mediators (Feuerstein et al., 1998; Dirnagl et al., 1999). De-
spite these well described inflammatory events after ischemia, the
main impact of postischemic inflammation (beneficial or detri-
mental) is controversially discussed (del Zoppo et al., 2001;
Feuerstein and Wang, 2001).
There is striking evidence that the infiltration of activated
polymorphonuclear neutrophils (PMNs) (Kochanek and Hal-
lenbeck, 1992; Jean et al., 1998; Prestigiacomo et al., 1999) into
the injured parenchyma and the activation of microglia (Banati
and Graeber, 1994; Kreutzberg, 1996; Minghetti and Levi, 1998)
are playing an important role in the pathology of cerebral
ischemia.
It is suggested that activated PMNs contribute to tissue dam-
age by the release of oxygen radicals, proteases, and proinflam-
matory cytokines like TNF (tumor necrosis factor) (Barone et
al., 1991; Jordan et al., 1999). As evidence, experimental strategies
by avoiding PMN infiltration into the injured parenchyma are
neuroprotective (Heinel et al., 1994; Beray-Berthat et al., 2003b;
Miljkovic-Lolic et al., 2003). However, other studies failed to
provide clear evidence of a cause–effect of PMN contribution to
neuronal damage after ischemia (Hayward et al., 1996; Fass-
bender et al., 2002; Beray-Berthat et al., 2003a;Harris et al., 2005).
Similarly controversial findings exist regarding the role of mi-
croglia after ischemia. Several studies demonstrated the neuro-
toxic properties of activated microglia after ischemic or excito-
toxic damage (Giulian et al., 1993; Kim andKo, 1998; Rogove and
Tsirka, 1998; Yrjanheikki et al., 1999), whereas considerable evi-
dence shows that microglia triggered by injured/dying neurons
mediate a reduction of neuronal damage and induction of tissue
repair (Morioka et al., 1991; Rapalino et al., 1998; Streit, 2002;
Kohl et al., 2003; Kitamura et al., 2004; Shaked et al., 2005; Ha-
yashi et al., 2006; Lalancette-Hebert et al., 2007).
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Considering these controversial findings on the role of PMNs
and microglia during transient ischemia, strikingly few studies
have evaluated the direct effect of these immune cells on neuronal
survival/damage (Dinkel et al., 2004; Mitrasinovic et al., 2005).
Despite that, although the combined recruitment of both cell
types to tissue sites affected by cerebral ischemia is well estab-
lished, a potential direct interaction of both immune cell types
has not been investigated in depth. Two recent studies demon-
strated a possible microglia–PMN interaction. By histology, mi-
croglia with engulfed PMNs were observed in zones of focal ce-
rebral ischemia in vivo (Denes et al., 2007; Weston et al., 2007).
To better understand the complexity of cellular inflammation
after experimental ischemia, we investigated the individual im-
pact of PMNs, microglia, and macrophages on neuronal survival
after ischemia and studied how these cells interact during the
inflammatory response. To achieve this, we used an inflamma-
tion model that comprises oxygen–glucose deprivation (OGD)
in organotypic hippocampal slice cultures (OHCs) as ischemic
model and the application of immune cells onto the OHCs as
simulation of the postischemic immune cell infiltration into the
injured parenchyma.
Materials andMethods
Induction of focal cerebral ischemia by middle cerebral artery
occlusion with endothelin-1
Focal cerebral ischemia was induced by occlusion of the left middle ce-
rebral artery (MCA) via intracerebral microinjection of endothelin-1
(ET-1), following Sharkey andButcher (1995) andBaldauf andReymann
(2005). Briefly, anesthesia was induced with halothane in a mixture of
nitrous oxide and oxygen (50:50), and maintained with 2–3% halothane
(Sigma-Aldrich) via a rat anesthetic mask (Sto¨lting). A 29 gauge cannula
was inserted through the brain close to the MCA. Ischemia was induced
by injection of 376 pmol of ET-1 (Sigma-Aldrich). The animals were
killed by an overdose of chloral hydrate (Sigma-Aldrich) after 1 d. Frozen
brains were cut coronally and 30 m slices were taken for additional
staining.
Organotypic hippocampal slice cultures
Hippocampal interface organotypic cultures were prepared as previously
described (Stoppini et al., 1991; Neumann et al., 2006) from postnatal
day 7–9Wistar rats (HarlanWinkelmann). For two-photon microscopy
experiments, hippocampal slice cultures were prepared from transgenic
B6.Cg-TgN(Thy1-YFP)16Jrs mice (The Jackson Laboratory; distributed
by Charles River), which express enhanced yellow fluorescent protein
(EYFP) at high levels in subsets of central neurons, including the pyra-
midal cells of the hippocampus (Feng et al., 2000). Hippocampi were
dissected and transversely sliced at 350 m thickness with a McIlwain
tissue chopper (The Mickle Laboratory Engineering). Slices were trans-
ferred to Millicell membranes (Millipore). Cultures were maintained at
37°C in 1 ml of serum-based medium containing 50% MEM-Hanks,
25% HBSS, 17 mM HEPES, 5 mM glucose, pH 7.8 (Cell Concepts), 1 mM
L-glutamine (Biochrom), 25% horse serum (Invitrogen), and 0.5% gen-
tamycin (Biochrom) for 2–3 d. Cultures were thenmaintained in serum-
free medium (Neurobasal A medium with B27 complement, 5 mM glu-
cose, 1 mM L-glutamine). The OHCs were selected by adding a nontoxic
concentration of propidium iodide (PI) (2 g/ml; Sigma-Aldrich) 12 h
before the experimental start. PI-negative slices were considered to be
healthy, and only these slices were used for the experiments.
Isolation of polymorphonuclear granulocytes (PMNs)
Human PMNs were prepared from venous blood (8 ml) of healthy vol-
unteers. The rat PMNs were prepared from blood of Wistar rats (Harlan
Winkelmann). Briefly, anesthesia in rats was induced with chloral hy-
drate followed by opening the thorax. The left ventricle of the heart has
been punctured under direct visualization, and 10–12 ml of blood was
obtained per rat. The blood was collected in a vacutainer containing
EDTA (BD Biosciences). The anticoagulated whole blood was carefully
layered over 5 ml of the density gradient Polymorphprep (Axis-Shield).
Samples were centrifuged for 35min at 500 g. After centrifugation, two
leukocyte bands were visible. The top band contained the fraction of
mononuclear cells, and the lower band contained the fraction of PMNs.
The fraction of PMNs was collected by pipetting. PMNs were washed
with PBS. Contaminating erythrocytes were removed by hypotonic lyses
in plainH2O for 20 s followed by addition of the same volume of 2 PBS
to restore osmolarity. PMNs were pelleted and resuspended in DMEM/
10% fetal calf serum (FCS). Cell yield (1.5  107 cells per preparation)
was determined by counting cells in a “Neubauer” hemocytometer, and
viability (99%) was assessed by trypan blue staining (0.4% trypan blue
in PBS; Sigma-Aldrich). PMN preparations contained 95% neutro-
phils assessed by hematoxylin/eosin staining on smears, whereas only a
few basophil and eosinophil granulocytes could be detected. No mono-
cytes or lymphocytes contaminated the preparation.
Isolation of rat primary microglia
Primarymicroglia cultures were prepared from postnatal day 2–3Wistar
rats (Harlan Winkelmann) and cultured in DMEM supplemented with
10% FCS (Biochrom), 1% Pen/Strep (Biochrom), and 1% L-glutamine
(Biochrom). After 6 or 7 d of primary cultivation, microglia cells were
separated from other cell types by shaking, placed in a 25 ml flask (TPP)
at a density not exceeding 5 105 cells/ml andmaintained in 5%CO2 at
37°C for 2 d. Cultures consisted of 95%microglia cells as determined by
staining with Alexa 568-conjugated Griffonia simplicifolia isolectin B4
(Invitrogen).
Culture of macrophage cell line RAW 264.7
The macrophage cell line RAW 264.7 was cultured in DMEM supple-
mented with 10% FCS (Biochrom), 1% Pen/Strep (Biochrom), and 1%
L-glutamine (Biochrom) at a density not exceeding 1 106 cells/ml and
maintained in 5% CO2 at 37°C.
Application of cells onto OHCs
Isolated primary microglia or macrophages were trypsinated (trypsin/
EDTA; Biochrom), centrifuged at 500  g for 2 min, and finally resus-
pended in Neurobasal medium (Invitrogen). PMNs were freshly pre-
pared shortly before the experimental start. PMNswere also resuspended
in Neurobasal medium. The cells were applied directly onto 10-d-old
OHCs in a volume of 1 l of Neurobasal medium containing 8  104
microglia, macrophages, or 1 105 PMNs. Viability of microglia, mac-
rophages, and PMNs after application onto the OHC was confirmed in
initial experiments by previous staining with 5-chloromethylfluorescein
diacetate (CMFDA) (Invitrogen) and by time-lapse microscopy of these
cells (data not shown). As indicated, OHCs were fixed with 4% parafor-
maldehyde (PFA) and mounted with 3:1 PBS/glycerol. OHCs were then
further analyzed with the indicated microscopy approach.
Oxygen–glucose deprivation
The membrane inserts carrying up to three OHCs were placed into 1 ml
of glucose-free medium in sterile six-well culture plates (TPP) that had
previously been saturated with 5% CO2/95% N2 for 10 min. Then OHC
were subjected to the OGD [40min of OGD in a temperature-controlled
hypoxic chamber (Billups-Rothenberg); no glucose medium; N2/CO2
atmosphere] before retransfer into normal conditions. Control cultures
were kept in regular medium (plus glucose) under normoxic conditions.
The cultures were analyzed as indicated by individual experiments 24 or
48 h after OGD.
Analysis of cell death
Cell death was evaluated by cellular incorporation of PI at 24 or 48 h after
OGD. Cultures were incubated with PI-containing medium (10 M) for
2 h at 33°C. Fluorescent images were acquired in a semiautomatic man-
ner (Nikon motorized stage; LUCIA software) and analyzed by densi-
tometry to quantify necrotic cell death (LUCIA Image analysis software).
Based on transmission light images, the area of analysis was determined
such that only the CA area (CA1–3) was analyzed, whereas the dentate
gyrus was excluded. Background correction was performed automati-
cally by a control square (150  150 m) in the stratum moleculare
outside the pyramidal cell layer. To combine data from individual exper-
iments, the densitometric mean value of the respective insult of an indi-
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vidual experiment was set to the value of 1 and given as relative fluores-
cence intensity. All other data are given as relative fluorescence intensity
of the insult damage.
Electrophysiology
Wistar rats (25 d old) (HarlanWinkelmann) were killed by a blow on the
neck. After decapitation, the brain was quickly removed and placed into
ice-cold artificial CSF (ACSF) having the following composition (inmM):
124NaCl, 4.9 KCl, 1.3MgSO4, 2.5 CaCl2, 1.2 KH2PO4, 25.6 NaHCO3, 10
D-glucose, saturated with 95% O2 and 5% CO2, pH 7.4. Transverse hip-
pocampal slices (350m thickness) with adjacent subicular and entorhi-
nal cortices were prepared using a vibratome (microm HM 650V). The
slices were placed on Millicell membranes in a six-well cluster dish
(Sigma-Aldrich) with 1 ml of high K culture media [25% horse serum
(Invitrogen); 40%Eagle’s Basal EssentialMedia (BME) (Sigma-Aldrich);
25% Earle’s balanced salt solution (Sigma-Aldrich); 10% 250 mM Na-
HEPES in BME, pH 7.3; 0.5 mM L-glutamine (Sigma-Aldrich); 28 mM
glucose, pH 7.32]. One hour after preparation, 2 l of high K culture
media containing 4 105 PMNs and 2 l of cell-free media for control
experiments, respectively, were applied on top of the slices and incubated
overnight at 33°C in a humidified carbogen atmosphere (95% O2/5%
CO2). Then, the slices were transferred into an interface-type recording
chamber saturated with carbogen at 33 1°C and constantly superfused
with ACSF. Synaptic responses were elicited by stimulation of the Schaf-
fer collateral–commissural fibers in the stratum radiatum of the CA1
region using lacquer-coated stainless-steel stimulating electrodes. Glass
electrodes (filledwithACSF, 1–4M) were placed in the apical dendritic
layer to record field EPSPs (fEPSPs). The initial slope of the fEPSP was
used as a measure of this potential. The stimulus strength of the test
pulses was adjusted to 30% of the EPSP maximum. During baseline
recording, three single stimuli (10 s interval) were averaged every 5 min.
After tetanization, recordings were taken as indicated in Figure 1C. Once
a stable baseline had been established, long-term potentiation was in-
duced by application of four times two-paired pulses in intervals of 200
ms (theta burst). The interval between the paired pulses was 10 ms, and
the width of a single pulse was 0.2 ms.
Two-photon microscopy
For two-photon microscopy, PMNs were labeled with Cell Tracker
Orange [5-(and-6)-(((4-chloromethyl)benzoyl)-amino)tetramethyl-
rhodamine (CMTMR)] (7.5 M in PBS, 10 min, room temperature;
Invitrogen). At different time points after OGD induction, the OHCs
were fixed with 4% PFA, subsequently mounted and subjected to three-
dimensional two-photon microscopy. In other experiments, viable
OHCs were analyzed. PMNs were labeled with CMFDA and microglia
withCMTMRandboth applied ontoOHCs. Twohours after experimen-
tal start, the OHCs were placed in a custom-built chamber supplied with
37°C and 5% CO2 directly under the microscope. The two-photon mi-
croscope setup was used exactly as previously described (Neumann et al.,
2006). OHCs prepared from transgenic B6.Cg-TgN(Thy1-YFP)16Jrs
mice (Feng et al., 2000) were imaged in a modus at 800 and 920 nm
wavelength of the laser (MaiTai; Spectra Physics) using a scanning win-
dow of 90  150 m size. With a resolution in Z of 1 m, the entire
thickness of the OHC was scanned, first at 920 nm and then at 800 nm
wavelength with no filter. The emission of EYFP at 800 nmwas negligible
as was the emission of Cell Tracker Orange at 920 nm. Image stacks were
exported as two independent 16-bit multilayer TIFF stacks and subse-
quently reconstructed using the Volocity software package
(Improvision).
Confocal microscopy
Cultures were examined with a confocal microscope equipped with a
40magnification Plan Neofluar 0.75 objective, an argon laser emitting
at 488 nm, and a helium/neon laser emitting at 543 nm. Multitracking
was used to avoid cross talk between channels. Imageswere analyzedwith
Carl Zeiss software (Pascal; Carl Zeiss).
Time-lapse video microscopy
The cellular dynamics of PMN–microglia interaction were investigated
using OHCs or an in vitro PMN–microglia coculture.
Time-lapse microscopy of OHCs. Fluorescently labeled PMNs
[7-amino-4-chloromethylcoumarin(CMAC)] andmicroglia (CMTMR)
were applied onto OHCs. Two hours after start of the experiment, the
OHCs were placed in a custom-made chamber (Incubator S-M; Pecon)
adjusted to 37°C and 5% CO2 (CTI-Controller 3700 digital; Tempcon-
trol 37–2 digital; Pecon).
Time-lapse microscopy of PMN–microglia coculture. Primary microglia
were cultured onto Matrigel-coated surfaces in a 12-well plate (Falcon;
BD Biosciences Discovery Labware). Matrigel basement membrane ma-
trix (BD Biosciences), containing laminin as a major component, was
diluted in ice-cold DMEM (ratio, 1:20) and polymerized at 37°C for 30
min. Thereafter, 2  105 microglia/well were placed and recovered for
1 d. Freshly prepared human PMNs were applied to the primary micro-
glia culture. If indicated, PMNs were CMFDA labeled prior to applica-
tion. Thirty minutes after the experimental start, the coculture was
placed into the chamber as described above. The time-lapse microscope
was based on an Axiovert 200M (Carl Zeiss) stage equipped with a 10,
numerical aperture (NA) 0.3 lens or a 32, NA 0.5 lens (Carl Zeiss) and
a CCD camera (Axiocam MRm; Carl Zeiss). Images were recorded at
defined time intervals. The datawere subsequently analyzedwith theCarl
Zeiss software (AxioVs40 V4.5).
Statistical analysis
All data are given as mean SEM. Statistical analysis was performed by
one-way ANOVA followed by post hoc comparison (Tukey’s test). A
value of p 0.05 was considered statistically significant.
Results
PMNs infiltrate the brain parenchyma after focal ischemia
Given the heterogeneity of the data concerning the relevance of
peripheral immune cells for ischemia-induced neuronal damage,
we first wanted to investigate which type of peripheral immune
cell was initially recruited into the injured brain parenchyma after
transient ischemia. To this end, endothelin was injected directly
above the MCA. Endothelin as vasoconstrictor occluded the
MCA for 30 min. We found that, 1 d after injection,
endothelin-mediated transient focal ischemia induced a cellular
infiltrate that was mainly composed of PMNs as detectable from
the characteristic lobulated nuclei of infiltrating cells in immu-
nohistological sections of the damaged area (Fig. 1A). We found
no marked infiltration with other peripheral immune cells such
asmacrophages or lymphocytes. Thus, the acute cellular infiltrate
of the ischemia-injured brain in vivo was dominated by PMNs,
suggesting a prominent role of this immune cell type for the
additional development of neuronal damage.
Application of human PMNs onto organotypic hippocampal
cultures does not influence neuronal survival
Following the results of the in vivo ischemia-induced recruitment
of PMNs (Fig. 1A), one goal of this study was to clarify the role of
PMNs for the development of neuronal viability. To this end, we
chose a well established model of ischemic injury in situ using
OHCs that maintain many characteristics of true brain–paren-
chyma, especially the complex three-dimensional structure of
neuronal circuits, yet allow for precise control of cellular or hu-
moral factors impacting on neuronal viability as described previ-
ously (Neumann et al., 2006). The first step was to evaluate
whether PMNs as such had a detrimental effect on neuronal via-
bility in healthy OHCs. Because of the very limited availability of
primary rat PMNs, we chose to use human PMNs throughout
this study and performed only key experiments with primary rat
PMNs. Direct application of up to 2  105 human PMNs onto
control OHCs had no effect on neuronal viability in the cornu
ammonis (CA1–CA3) area after 24 h (Fig. 1B). Additionally, we
investigated the effect of PMNs on neuronal function by electro-
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physiological EPSP recording with subsequent LTP induction in
1 d in vitro (DIV) hippocampal slices. This approach provides
two critical parameters of neuronal health. First, the shape and
value of the synaptic signal reflects the quantity and integrity of
the involved synapses. Second, the amount and persistence of the
synaptic potentiation represents a highly sensitive marker for
neuronal viability and functionality. According to the EPSP sig-
nal, neither the persistence nor the amount of the LTP was dis-
turbed by application of 4  105 PMNs onto the 1 DIV hip-
pocampal slices (Fig. 1C). These experiments indicated that
PMNs derived from healthy human volunteers did not cause
neuronal cell loss or neuronal electrophysiological disturbance in
rat OHCs.
PMNs exacerbate neuronal damage after
oxygen–glucose deprivation
To examine the effect of PMNs on CNS cells after ischemia, we
simulated the PMN infiltration into the brain parenchyma by
direct application of PMNs onto post-OGD OHCs (Fig. 2A).
Application of increasing numbers of PMNs onto theOHCs after
OGD resulted in a significant exacerbation of neuronal damage
compared with OGD-induced neuronal damage alone (Fig. 2B).
Representative fluorescence images of the densitometric quanti-
fication (Fig. 2B) are shown in Figure 2C. These data suggest that
PMNs can aggravate the outcome of ischemic neurological in-
sults after 24 h. For all the following experiments involving direct
application of PMNs onto OHCs, 1 105 PMNs were used.
PMNsmigrate rapidly into hippocampal slices independent
of OGD-induced neuronal damage
We had previously shown that microglia can migrate deeply into
OGD-damaged OHCs to provide neuroprotection (Neumann et
al., 2006). Thus, we speculated that also PMNs might immigrate
into OHCs, albeit with a neurotoxic effect after OGD. To test this
assumption directly, we subjected cocultures of OGD-treated
OHCs and PMNs to two-photon microscopy as previously de-
scribed (Neumann et al., 2006). In this model, OHCs are made
from mice that express EYFP under a specific Thy-1 promoter
that leads to strong expression of the transgene in hippocampal
neurons (Feng et al., 2000). We observed the rapid migration of
PMNs into the brain tissue after 1 h under basal conditions.
However, the PMN immigration rate into OGD-damaged slices
was indistinguishable from that observed under control condi-
tions (Fig. 3A,B). Also, at later time points, we detected a uni-
form distribution of PMNs within the slice and no differences
between OGD conditions and basal conditions were observed
(Fig. 3A–F). Additionally, we studied the morphology of EYFP-
positive neurons within the OHCs after PMN application. The
application of PMNs onto hippocampal slices without OGD
showed morphologically intact neurons (neuronal body, den-
drites, axons) at all analyzed time points (Fig. 3A,C,E). In con-
trast, OGD slices containing PMNswere characterized by a severe
loss of axons and dendrites after 6 h (Fig. 3D) and an almost
complete loss of EYFP-positive neurons associated with the ap-
pearance of subcellular granular material, presumably stemming
Figure 1. PMNs infiltrate the brain parenchyma 1 d after in vivo focal ischemia.A1, Hematoxylin/eosin staining of a coronal section shows an ischemic lesion in the cortex 1 d after focal ischemia.
A2, Higher magnification from the edge of the ischemic lesion shows polymorphonuclear cells pointed by black arrows. A3, The black box in A2 is enlarged in A3 and demonstrates the occurrence
of PMNs shown by the polymorph nucleus. Scale bar: A1, 200m; A2, 20m; A3, 10m. B, A total of 2 10 5 PMNs was applied in 1l onto untreated OHCs. Quantification of neuronal death
in CA1–3was determinedby PI incorporation after 24 h [control (CTRL) vs PMNs, nonsignificant (n.s.);n 9/bar]. In the panel next to the bar chart are representative PI fluorescent images showing
neuronal death in CA1–3 after 24 h. C, Because of the nearly twice greater surface of 25-d-old slices, we applied 4 10 5 PMNs in 2l onto 1 DIV slices. The recording shows that applied PMNs did
not influence EPSP signal nor the amount and persistence of LTP (CTRL vs PMNs, n.s.; CTRL 11; PMNs, n 6). Analogous traces represent typical recordings of single experiments taken 10 min
before tetanization and 60 min after tetanization. Error bars indicate SEM.
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from neuronal apoptosis and necrosis, in the CA1 area after 24 h
(Fig. 3F). We also noted the appearance of holes in the otherwise
homogenous layer of intact neuronal somata (Fig. 3F, arrow-
heads), which probably showed the loss of cell bodies in the re-
spective areas. Thus, although PMNs have the ability to invade
OHCs under normal conditions, they do not cause neuronal
damage, unless this process is initiated by OGD.
Exogenous microglia counteract the neurotoxicity of PMNs
We previously showed that microglia can have a neuroprotective
function in the OGD-induced neuronal damage within OHCs
(Neumann et al., 2006). We next asked whether this might also
hold true for the PMN-induced neurotoxicity. The direct appli-
cation of PMNs (Fig. 4A), microglia, or macrophages
(RAW264.7) to control OHCs had no effect on neuronal viability
in the CA area after 48 h (Fig. 4B,C). However, although the
presence of PMNs in OGD-treated OHCs showed a strong exac-
erbation of OGD-induced neuronal damage after 24 and 48 h
(Fig. 4B,C), microglia application resulted in a significant reduc-
tion of OGD-induced neuronal damage after 48 h but not after
24 h (Fig. 4B,C). No significant effect on neuronal death was
observed after application of macrophages (Fig. 4B,C). We
next wanted to analyze whether microglia were also able to
counteract the massive neurotoxicity induced by PMNs.
Therefore, we applied PMNs (1  10 5) in combination with
microglia or macrophages (0.8  10 5 each) directly onto the
OHCs (Fig. 4D). The combined application of PMNs and
microglia resulted in a significant reduction of PMN-caused
exacerbation of neuronal damage after OGD (Fig. 4E). In con-
trast, no significant effect was detected by simultaneous appli-
cation of PMNs and macrophages. These data suggested that
there might be a direct interaction between microglia and
PMNs, which significantly attenuated the deleterious effects of
PMNs on neuronal survival.
Figure 2. Polymorphonuclear granulocytes (PMNs) exacerbate neuronal damage after OGD.A, Different numbers of PMNs (0.5 10 5, 1 10 5, 2 10 5) were applied onto OHCs after OGD.B,
Quantification of neuronal death in CA1–3was determined by PI incorporation after 24 h (***p 0.001 vs OGD; n 7/bar). Error bars indicate SEM. CTRL, Control. C, Representative PI fluorescent
images showing neuronal death in CA1–3 after 24 h.
Figure 3. The migration of PMNs into the OHCs under basal and OGD conditions. PMNs (1  10 5) were labeled with CMTMR (red) and then directly applied onto OHCs prepared from
B6.Cg-TgN(Thy1-YFP)16Jrsmice (neurons: green). At indicated time points (basal, 1, 6, 24 h; OGD, 1, 6, 24 h), sliceswere fixedwith 4%PFA and subsequently Z-stacks through thewhole OHCswere
performed by using two-photonmicroscopy. A–F, Images show three-dimensional reconstruction of the OHCs and the representative focal plane (middle of OHCs) in the CA1 neuronal layer at the
indicated time points after PMN application under basal conditions (A, C, E) or after OGD (B, D, F ). Scale bars, 20m.
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Microglia engulf PMNs within the OHCs
Based on these findings, we investigated a possible direct micro-
glia–PMN interaction in OGD-damaged OHCs. Therefore, we
applied fluorescently labeled PMNs and microglia onto the
OHCs. Confocal microscopy analyses revealed that exogenous
microglia had engulfed PMNs in OGD-treated OHCs (Fig. 5A).
By means of two-photon microscopy and three-dimensional re-
construction of individual microglia, we found that endogenous
as well as newly applied microglia were able to fully incorporate
single or multiple PMNs within the OHCs (Fig. 5B).To investi-
gate the cellular dynamics of such an engulfing process in more
detail, we applied fluorescently labeled PMNs andmicroglia onto
OHCs and recorded their migratory behavior by time-lapse mi-
croscopy. Surprisingly, we observed that, in addition to inactive
(immotile and presumably apoptotic) PMNs, microglia were
able to also engulf active (motile and viable) PMNs (Fig. 5C;
supplemental movie 1, available at www.jneurosci.org as supple-
mental material).
Microglia engulf viable, motile, nonapoptotic PMNs
The previous experiments suggested that the microglia was able
to engulf fully viable PMNs. However, although the phagocytosis
of apoptotic cellularmaterial bymicroglia is a relatively common
process (Stolzing and Grune, 2004; Takahashi et al., 2005; Chan
et al., 2006), the capture of active and viable cells bymicroglia has
not been observed before. Phototoxicity and bleaching prevented
us from performing hour-long time-lapse sequences on individ-
ual OHCs. However, in several instances, we were able to docu-
ment the uptake of live PMNs by parenchymal microglia within
the brain slices in a manner very similar to the one observed
before for isolated microglia (supplemental movie 6, available at
www.jneurosci.org as supplemental material), which suggests
that the behavior of the externally addedmicroglia was similar to
the parenchymal cells. The related low frequency of phagocytosis
events in individual image sequences did not allow performing a
thorough quantitative analysis of PMN phagocytosis in this ex
vivo model system. We therefore performed cell culture experi-
ments in vitro. PMNs (3  105) were cocultured with primary
microglia (0.75  105) in vitro. These experiments allowed to
clearly visualize the engulfing process ofmotile PMNs by individ-
ual microglia (Fig. 6A,B) and demonstrated that before being
engulfed and phagocytosed PMNs could exhibit profoundmotil-
ity over long time periods (Fig. 6A,A*).
We frequently observed that microglia adopted a “chasing
behavior” while attempting to engulf PMNs, either including cel-
lular protrusions (supplemental movie 2, available at www.
jneurosci.org as supplemental material) or the whole cell bodies
(Fig. 6B; supplemental movie 3, available at www.jneurosci.org
as supplemental material). Because also immotile (presumably
apoptotic or preapoptotic) PMNs were engulfed by microglia
Figure 4. Exogenousmicroglia counteract PMN neurotoxicity. In A–C, the effects of PMNs, microglia, andmacrophages (RAW264.7) were examined individually. A, PMNs (1 10 5), microglia
(0.8 10 5), andmacrophages (0.8 10 5) were applied directly onto the OHCs after OGD. B, Quantification of neuronal death in CA1–3was determined by PI incorporation after 24 and 48 h (24
h: ***p 0.01 vs PMNs; 48 h: ***p 0.001 PMNs vs OGD, **p 0.01MIC vs OGD; n 9/bar). C, Representative PI fluorescent images showing neuronal death in CA1–3 48 h after OGD. InD–F,
the effect of combined application of PMNs/microglia or PMNs/RAW264.7 was studied. D, PMNs were applied directly onto the OHCs together with microglia or macrophages after OGD. E,
Quantification of neuronal death in CA1–3 was determined by PI incorporation after 24 h (***p 0.001 PMNs vs PMNs/MIC; n 9/bar). Error bars indicate SEM. F, Representative PI fluorescent
images showing neuronal death in CA1–3 24 h after OGD. MIC, Microglia; RAW, RAW264.7.
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(Fig. 6B; supplemental movie 4, available at www.jneurosci.org
as supplemental material), we next addressed the question of
whether engulfed PMNs always exhibited signs of proapoptosis.
Therefore, we transferred PMNs to primary microglia and added
FITC-labeled Annexin V to the coculture. Annexin V binds to
phosphatidylserine on the outer side of the membrane of cells
that have already initiated the apoptotic cascade (Fadok et al.,
1992). Thus, in our coculture system, proapoptotic cells (espe-
cially PMNs)were detectable by an increased FITC signal (Fig. 7).
This set of experiments revealed that microglia indeed engulfed
both proapoptotic PMNs and healthy PMNs (Fig. 7; supplemen-
tal movie 5, available at www.jneurosci.org as supplemental ma-
terial). Our experimental setup required a 48 h resting period of
primary microglia before use. Attempts to apply microglia di-
rectly shaken from the culture were not successful because these
cells were not very active and partially died during the first hour
of investigation. Thus, it could not be excluded that microglia
were activated by the necessary culture conditions. Microscopic
analysis of the cells showed that untreated microglia were very
adhesive to plastic but, in the presence of supernatant of OGD-
treated OHC or PMNs, detached from the plastic surface and
obtained a motile morphology (supplemental Fig. 1, available at
www.jneurosci.org as supplemental material), which suggested,
that indeed the microglia was activated by
the presence of PMNs or the supernatant
of OGD-treated OHC. Thus, it was possi-
ble that the observed phagocytosis behav-
ior was a general phenomenon of activated
macrophage-like cells and not specific for
microglia. To test this assumption, we
compared the ability of primary microglia
with peritoneal macrophages freshly iso-
lated from rats by peritoneal lavage with
PBS. Analysis showed that despite being
motile and frequently touching or drag-
ging PMNs in the culture peritoneal mac-
rophages never engulfed PMNs, whether
apoptotic or alive (supplemental movie 7,
available at www.jneurosci.org as supple-
mental material), whereas microglia
cocultured in the same experiment phago-
cytosed on average 2.6 PMNs per cell (sup-
plemental Fig. 2 and movie 8, available at
www.jneurosci.org as supplemental mate-
rial). Thus, the ability to phagocytose live
or dead PMNs seemed to be specific for
microglia activated by the presence of
PMNs or the supernatant of OGD-treated
OHC and was not observed with periph-
eral macrophages, at least from the
peritoneum.
Blocking the engulfment process of
PMNs bymicroglia worsens the
outcome of neuronal viability
after OGD
Next, we investigated whether the engulf-
ment of PMNs by microglia had any con-
sequence on neuronal viability after OGD.
It has been shown that apoptotic PMN
cells can be internalized by binding to the
v3-integrin receptor on macrophages.
In addition, lectin-like receptors have been
shown to be involved in this process (Fadok et al., 1998;Meszaros
et al., 1999). Thus, we evaluated the potential of the integrin-
blocking tetrapeptide RGDS (Arg-Gly-Asp-Ser) and the lectin
inhibitor N-acetyl glucosamine (GlcNAc) to block the engulfing
process by preincubating primary microglia with the reagents
before adding PMNs to the culture. We distinguished between
engulfment of motile or immotile PMNs by time-lapse micros-
copy. RGDS and GlcNAc blocked the engulfing of both immotile
and, interestingly, also motile PMNs, highly significantly (Fig.
8A). Thereby GlcNAc was more efficient than RGDS (Fig. 8A).
We also noted a slight synergistic effect on the blockade of the
engulfment process when both substances were combined. This
synergistic effect was more pronounced in the engulfment of
nonmotile cells (Fig. 8A). Additionally, we always observed al-
tered microglia–PMN interaction patterns in the presence of
RGDS and GlcNAc.Whereas untreatedmicroglia bound and en-
gulfed PMNs, treated microglia bound several PMNs but mostly
failed to ingest them (Fig. 8B).
An important question was whether interfering with the en-
gulfment process affected the neuronal viability after OGD. To
test this, we applied PMNs andmicroglia simultaneously onto the
OHCs after OGD. Microglia and OHCs were also preincubated
with RGDS/GlcNAc before application. Indeed, the presence of
Figure 5. Microglia phagocytose PMNs within the OHCs. PMNs (1 10 5) were labeled with CMFDA (green) (A, B) or CMAC
(blue) (C) andmicroglia with CMTMR (red) and then directly applied onto OHCs. A, OHCwas fixed with 4% PFA and subsequently
investigated using confocal microscopy. B, The images from a living slice show the three-dimensional reconstruction of one
microglia that had already phagocytosed two PMNs (arrows) and was in progress to phagocytose another PMN (asterisk). The
dotted line indicates the contact between microglia and PMNs. C, Time-lapse video microscopy was performed 4 h after experi-
mental onset. Images show the engulfing of amotile PMNby themicroglia. Thewhite line indicates themigration pathway of the
PMN. Themicroglia contacted the PMN at the time (3min after start of time-lapse imaging) at which the PMN showed a velocity
of 7.6m/min. The white dotted line shows the contact point between microglia and PMN (supplemental movie 1, available at
www.jneurosci.org as supplemental material). Scale bars: A, 20m; B, 5m; C, 10m.
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RGDS or GlcNAc alone, and, more effi-
ciently, in combination strongly reduced
the neuroprotective function of coapplied
microglia in this model (Fig. 8C). In addi-
tion, we obtained similar results by using
primary rat PMNs, confirming that the
observed behavior was specific for PMNs
(Fig. 8C).
Thus, blocking the engulfment of
PMNs bymicroglia severely compromised
the neuroprotective function that micro-
glia exerted on neurons on OGD exposure
pointing to a physiological role of this cel-
lular function of microglia.
Discussion
This study was designed to determine the
role of individual cell types of the innate
immune system that contribute to the
postischemic inflammation after cerebral
ischemia. Taking advantage of our neu-
roinflammation model, we were able to
simulate the migration and infiltration of
these cells to the site of damage in the neu-
ronal tissue. It is generally accepted that
the main immune cells involved in the
inflammation-induced secondary neuro-
nal damage are PMNs, microglia, and
macrophages, which all are recruited as
early as the postischemic inflammation is
initiated. However, PMNs and local mi-
croglia are the first cells present on site,
followed by peripheral microglia and
monocytes/macrophages. Although all
three cell types potentially exhibit cytotox-
icity by releasing noxious substances such
as cytokines, oxygen radicals, and proteases (Hallenbeck et al.,
1986; Barone et al., 1991; Minghetti and Levi, 1998), their indi-
vidual contribution for the overall damage remains unclear.
There is still an ongoing debate as to the importance of the
individual cell types in brain ischemia. In an attempt to overcome
this limitation, we chose to use a well established ex vivomodel of
neuroinflammation (Ullrich et al., 2001;Mitrasinovic et al., 2005;
Neumann et al., 2006). Using this model, we were now able to
demonstrate that indeed only PMNs sharply increased neuronal
damage associatedwith transient ischemia. Thiswas not a general
phenomenon of infiltrating phagocytes, because neither local nor
externally addedmicroglia normacrophages appeared to be neu-
rotoxic after cerebral ischemia. In fact, we and others previously
showed that local (Kohl et al., 2003) or externally added (Neu-
mann et al., 2006) microglia may even be neuroprotective in this
model. Our data provide strong evidence that PMNs are a critical
innate immune cell type that is responsible for the increase of
neuronal damage associated with ischemia. This finding is well in
linewith previous studies showing enhancedneuronal death after
ischemia in a dissociated neuronal culture (Dinkel et al., 2004).
Moreover, in vivo studies strongly correlate the degree of PMN
infiltration to the size of the neuronal damage (Beray-Berthat et
al., 2003b; Weston et al., 2007). Another study found a positive
correlation between the intensity of myeloperoxidase staining, a
hallmark of PMN activity, and the degree of neuronal damage in
the area of ischemia (Matsuo et al., 1994). This finding also
strongly supports the view that PMNs are critically involved in
the progress of postischemic neuronal damage.
Interestingly, the inhibition of reactive oxygen species (ROS)
productionbyNAD(P)H-oxidases, one of the key actions of inflam-
matoryPMNs (Segal, 2005), results in strongneuroprotective effects
in rodentmodels of ischemic stroke (Wang et al., 2006; L. L. Tang et
al., 2007).Moreover, interferingwith thehomingof immunecells by
an antiadhesive therapy has been shown to be neuroprotective
(Connolly et al., 1996; Yanaka et al., 1996). However, because this
approach affects indiscriminately all immune cell types, it did not
provide any suggestions as to whether PMNs might play a specific
role in this context. In addition, it is assumed that also cells of the
adaptive immune systemcan invade areas of ischemia-inducedneu-
roinflammation (Arumugam et al., 2005). Because their contribu-
tion is still unclear, ourmodel iswell suited to examine thismatter in
the future. In summary, in the line of these previous data and our
study, it seems likely that PMNs constitute an important neurotoxic
cell type under ischemic conditions. Because we did not find evi-
dence thatmicroglia andmacrophageswere neurotoxic, at least 48 h
after ischemia,weassumethat interferingwith the functionofPMNs
might be a particularly promising option to limit the extent of neu-
ronal damage after stroke.
A major conclusion from our study is that there seems to be a
naturalmechanism aiming precisely at this goal. After coapplying
microglia and PMNs onto ischemically damaged OHCs, we
found a strong decrease of neuronal damage compared with the
application of PMNs alone. This was a rather unexpected finding,
because numerous studies demonstrated that microglia preacti-
Figure 6. Microglia engulf motile PMNs. The panels show CMFDA (green)-labeled PMNs (3 10 5) cocultured with primary
microglia (0.75 10 5). Cellmovementswere recorded by time-lapsemicroscopy.A, The panel displays amicroglia that engulfed
amotile CMFDA-labeled PMN (arrow).A*, The image depicts the PMNmigration path (white line) before themicroglia contacted
and engulfed the PMN (red circle). The integrated white graph shows the PMN velocity of 5m/min at the time the microglia
had touched the PMN (supplemental movie 2, available at www.jneurosci.org as supplemental material). B, Images show the
engulfment of an immotile CMFDA-labeled PMN (arrow) (supplemental movie 4, available at www.jneurosci.org as
supplemental material). Scale bars, 10m.
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vated by inflammatorymediators are strongly neurotoxic (Arai et
al., 2004; Minghetti et al., 2004; Qin et al., 2004; Fordyce et al.,
2005; Huang et al., 2005). However, a close inspection of these
studies shows thatmicroglial activationwas achieved by exposure
tomicrobial products (Arai et al., 2004; Qin et al., 2004; Huang et
al., 2005) or viral particles (Lim et al., 2003; Minghetti et al.,
2004). Lipopolysaccharide (LPS) or viral particles are well known
to trigger a massive immune cell reaction via Toll-like receptors
(TLRs) (Kawai and Akira, 2006). Recent evidence suggests that,
even in the situation of stroke, which constitutes a sterile inflam-
mation, Toll-like mediated pathways can be triggered on micro-
glia (Lehnardt et al., 2007) or even directly onneurons (S. C. Tang
et al., 2007) and that this response increases neuronal damage after
stroke. However, the signaling induced by
bacterial TLR triggersmightwell bedifferent
from the one induced by endogenous in-
flammatory mediators because neurons,
which express both TLR-2 and -4 do not re-
spond to classical triggers of these receptors
such as peptidoglycan or LPS (S. C. Tang et
al., 2007). It might, therefore, be possible
that alsomicroglia are able to distinguish be-
tween microbial and other inflammatory
stimuli of the TLR system. In this concept,
microglia activated by nonmicrobial inflam-
mation might exert neuroprotective effects,
whereas microbial activation of microglia
preferentially triggers neurotoxicity.
Our study also provides insights into the
mechanism whereby this protection is ac-
complished.We demonstrate thatmicroglia
were very effective in phagocytosing invad-
ing PMNs. Macrophage-like cells are well
known to clear the inflamed tissue from cell
debris, such as apoptotic PMNs. Two recent
histological studies have also demonstrated
brain-resident microglia associated with
PMN-related debris in areas of ischemia-
induced neuronal damage (Denes et al.,
2007; Weston et al., 2007). However, our
data show that, in addition to proapoptotic
PMNs, also fully viable,AnnexinV-negative,
PMNs were effectively engulfed by
microglia.
In contrast, we have never observed mi-
croglia engulfingother typesof immunecells
such as freshly prepared lymphocytes and
monocytes, and in addition we did not find
engulfing of PMNs by macrophage lines or
freshly prepared peritoneal macrophages.
These findings underscore the specificity of
the microglia–PMN engagement. By time-
lapsemicroscopy,we observedmicroglia ex-
erting a PMN chasing behavior, either in-
cluding cellular protrusions or thewhole cell
bodies. To the best of our knowledge, the
phagocytosis of active and viable immune
cells by other immune cells has not been de-
scribed so far and therefore might represent
an entirely novel way of immune control.
This is probably attributable to the fact that
such a mechanism can only be revealed by
life cell imaging, which is technically chal-
lenging, especially with the cell types investigated in the current
study.
Given the fact that phagocytosis was inhibitable by RGDS
peptides and GlcNAc, we assumed that integrins such as vitro-
nectin receptors (Ruoslahti, 1996) or lectinsmediated the engulf-
ment process. Although this is well known for the uptake of ap-
optotic cells (Fadok et al., 1998; Meszaros et al., 1999), this
surprisingly also held true for the uptake of presumably live cells.
We cannot formally exclude that even Annexin V-negative cells
were already proapoptotic thereby exposing vitronectin or lectin
ligands. However, the fact that the cells were very motile argued
against this hypothesis, because one of the earliest events of apo-
ptosis is loss of migration (Savill et al., 2002).
Figure 7. Microglia engulf preapoptotic and nonapoptotic PMNs. FITC-conjugated Annexin V was added to the microglia–
PMN coculture, and thus proapoptotic cellswere visualized by an increased FITC signal. Thewhite thin arrowpoints on anAnnexin
V-positive PMN that was fully engulfed after 12 min. The arrowhead shows a PMN that was engulfed without exhibiting a FITC
signal at any time point of the engulfment process (supplemental movie 5, available at www.jneurosci.org as supplemental
material). Scale bars, 10m.
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Our study also indicates that interference with the phagocytosis
process by RGDS and GlcNAc abolished the neuroprotective func-
tion of microglia. It is well conceivable that dying PMNs mediate
neurotoxicityby the releaseof toxic intracellular compounds (Denes
et al., 2007; Weston et al., 2007), and that, consequently, prompt
phagocytosis of apoptotic PMNs by microglia might prevent the
secretion of toxic compounds. In the light of these findings, we pro-
pose that clearance of PMNs from the nervous tissue might be an
effective strategy to protect neurons from PMN neurotoxicity.
Whether the engulfment of viable PMNs contributes to this protec-
tion remains to be determined and requires to be examined in addi-
tional studies. In our system, phagocytosis of motile (presumably
viable) PMNswas evenmore frequent than the uptake of nonmotile
cells. Therefore, it appears unlikely that this process is irrelevant for
the protectionwe observed.Howmicroglia turn off the neurotoxic-
ity of a live PMN currently remains enigmatic. A possible mecha-
nism might include active interference with cytokine secretion and
productionofROS.Thismightbemediatedby the rapiddestruction
of engulfed PMNs, which appears to be happening to PMNs after
phagocytosis by microglia in our system. Finally, it has also been
shown thatmacrophages release immune-regulatory cytokines such
as TGF- (Savill et al., 2002) after uptake of apoptotic PMNs. A
similar process might also be exhibited by microglia after uptake of
PMNs, with TGF- mediating neuroprotection by reducing the
general inflammatory responses. Future studies are required to ver-
ify whether the processes observed in our ex vivo model are truly
active and physiologically relevant in vivo. If so, future therapies
might aim achieving neuroprotection by
supporting microglia activation, thereby
rapidly eliminating infiltrating PMNs from
the ischemic lesion site.
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